P2175
Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studiesEffect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trialsIn vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular diseaseIncretin-Based Therapy for Prevention of Diabetic Vascular ComplicationsEffect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analysesDiabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trialsMolecular Pathways Regulating Macrovascular Pathology and Vascular Smooth Muscle Cells Phenotype in Type 2 DiabetesAdvances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert ForumInterplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitusThe role of glucosamine-induced ER stress in diabetic atherogenesisEndothelial dysfunction in diabetes mellitus: possible involvement of endoplasmic reticulum stress?Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular ComplicationsPostprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinideEmerging options for the treatment of type 2 diabetes in Chinese patients: focus on arterial function and alogliptinVascular disease in diabetic women: Why do they miss the female protection?Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promiseRegenerative therapies for diabetic microangiopathyScreening for asymptomatic coronary artery disease in patients with diabetes mellitus: A systematic review and meta-analysis of randomized trialsA review about biomarkers for the investigation of vascular function and impairment in diabetes mellitusGlycaemic Effects of Non-statin Lipid-Lowering TherapiesPsychosocial Factors in Diabetes and Cardiovascular RiskRelationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysisEndothelial Microparticles Act as Novel Diagnostic and Therapeutic Biomarkers of Diabetes and Its Complications: A Literature ReviewAdministration of Traditional Chinese Blood Circulation Activating Drugs for Microvascular Complications in Patients with Type 2 Diabetes MellitusRemote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulcerationExtracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic reviewIdentification of coronary heart disease in asymptomatic individuals with diabetes mellitus: to screen or not to screenEndothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endotheliumEffectiveness of percutaneous coronary intervention with drug-eluting stents compared with bypass surgery in diabetics with multivessel coronary disease: comprehensive systematic review and meta-analysis of randomized clinical dataThe possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes.Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.Triglycerides and HDL cholesterol: stars or second leads in diabetes?How to define prehypertension in diabetes/metabolic syndrome.Smoking amplifies cardiovascular risk in patients with hypertension and diabetes.Hypertension and diabetes: should we treat early surrogates? What are the cons?Endothelial dysfunction as a target for prevention of cardiovascular disease.Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? YesShould we treat prehypertension in diabetes? What are the cons?White-coat hypertension should not be treated in subjects with diabetes.
P921
Q22242059-FCBFA1FD-3D81-4B0A-BEBD-A3C51996BA7EQ24628988-839D6DD3-C247-4B59-9A09-20E284F7293DQ24681371-25381D7F-9BD4-4B1D-AB39-E5AAFD461F36Q26765470-977BC9C0-E5E2-433A-BE19-E88ABB139D15Q26766025-06EB84B5-F321-4E66-A8E1-F41CB40614B0Q26766599-108FD65C-8649-46FC-95BD-34A7CE4248EFQ26782445-8F83E481-78E4-4C8F-8A12-3B40FE42F8B6Q26784022-AD000ED6-53DF-4437-9BD7-1DBEA98FFDC1Q26801308-8DB52B75-F813-482C-8B71-0376855DB9B1Q26830592-003EE3C7-FB77-4C75-898D-F4BB9B628BE3Q26851362-F8166B1D-3118-4109-BE88-709D6DE06916Q26859263-81D06A46-1D9E-4A11-B0B6-0BD3F126480FQ26865976-ED4AFA88-8D65-4EA3-9A07-1F37DBB8A1ABQ27008952-6D0572A1-DC23-48C3-BC7C-81A0FD18E6C2Q27011447-A350C714-CBB2-4232-99A5-BDD57FFC2B90Q27026834-8BD4FB30-CA24-4F40-B26A-30FB5D8EEE1AQ27027852-123F841A-E4C9-4BC3-879B-A8E9B013787AQ28067628-0025A207-F9BD-4A0F-B662-200AF87C9828Q28068779-226DC239-7375-4D52-B79D-A3A49529899FQ28070152-2B5B73FB-0CB3-4AEA-A3FB-4761BB130C98Q28070388-3A35FE81-324C-4BF9-90AE-255B0DFEDA94Q28071668-5302713F-12C8-4356-B500-7C35472E5F9FQ28071774-F5063529-0B9D-4A45-9525-9120FD7A7D0AQ28072087-719476C5-EEA6-402B-801A-88E2C95D70B9Q28078462-8BDCBF26-A1DE-4A5A-AE93-39A5164CA132Q28079163-34C2C305-C9E4-4311-AF2F-E98F5F3A362FQ28082405-A0DE63BA-EFBC-4EC7-BC61-0B61D55CCBB4Q28083730-9E3069D1-EF50-45DA-A48B-B0C35917E307Q28219326-FF029D72-8F80-4923-B718-A3C877D3E016Q30660247-4C94F0AE-448C-4848-8E91-80589BF04D76Q33344790-2DB94A9E-0160-48B2-963C-C5042FE7782DQ33515541-15F9CC21-05FB-45CF-AD6F-9A972DA7E2ADQ33610637-2C631B3B-8419-4F9C-9D82-FEB88643530DQ33610643-454F1D5B-6948-4136-B908-25B821F36F55Q33610650-068CBB4E-F43B-4E78-AADD-34D86799BE5DQ33610656-B7B836F8-B07E-4F32-864A-1659BCF8A7C5Q33610670-5F7C60F0-3292-4A69-A044-3DD94037E9CBQ33610682-9E8722A9-6088-4DC3-B661-8D0DF5B8A39BQ33610755-4B09EDDA-A701-4EDA-B71B-FBC6ED02B8D2Q33610794-AA158242-8B95-4134-8D74-7D09C02D1CEB
P921
description
Krankheit
@de
human disease
@en
malattia umana
@it
مرض يصيب الإنسان
@ar
name
angiopathie diabétique
@fr
angiopatia diabetica
@it
angiopatia diabètica
@ca
angiopatía diabética
@es
diabetic angiopathy
@en
diabetische Angiopathie
@de
diabetisk angiopati
@nn
Диабетическая ангиопатия
@ru
اعتلال وعائي سكري
@ar
糖尿病性血管障害
@ja
type
label
angiopathie diabétique
@fr
angiopatia diabetica
@it
angiopatia diabètica
@ca
angiopatía diabética
@es
diabetic angiopathy
@en
diabetische Angiopathie
@de
diabetisk angiopati
@nn
Диабетическая ангиопатия
@ru
اعتلال وعائي سكري
@ar
糖尿病性血管障害
@ja
altLabel
Diabetische Makroangiopathie
@de
Diabetische Mikroangiopathie
@de
angiopatia diabetica
@es
diabetic vascular disorder
@en
vasculopathie diabétique
@fr
vasculopatia diabètica
@ca
prefLabel
angiopathie diabétique
@fr
angiopatia diabetica
@it
angiopatia diabètica
@ca
angiopatía diabética
@es
diabetic angiopathy
@en
diabetische Angiopathie
@de
diabetisk angiopati
@nn
Диабетическая ангиопатия
@ru
اعتلال وعائي سكري
@ar
糖尿病性血管障害
@ja
P486
P6366
P646
P1748
P1995
P2176
P2888
P2892
P31
P373
Diabetic angiopathy
P3827
diabetic-angiopathies
P486
P6366
2777660278
P646
/m/04lcpg5
P672
C14.907.320
C19.246.099.500
P699
DOID:11713